Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic

ZW Howe, S Norman, AF Lueken… - … : The Journal of …, 2021 - Wiley Online Library
Abstract Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and
Drug Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …
被引用次数：25 相关文章

Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic.

ZW Howe, S Norman, AF Lueken, E Huesgen… - …, 2021 - europepmc.org
Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and Drug
Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …

Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic.

ZW Howe, S Norman, AF Lueken… - …, 2021 - search.ebscohost.com
Abstract Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and
Drug Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …

Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic.

ZW Howe, S Norman, AF Lueken, E Huesgen… - 2021 - cabidigitallibrary.org
Abstract Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and
Drug Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …

Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic

ZW Howe, S Norman, AF Lueken… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and Drug
Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …